1. El Boustani, Maguie, Mouawad, Nayla, Abou Alezz, Monah. 2024. AP3M2: A key regulator from the nervous system modulates autophagy in colorectal cancer. In Tissue & cell, 91, 102593. doi:10.1016/j.tice.2024.102593. https://pubmed.ncbi.nlm.nih.gov/39488930/
2. Huang, Ming-Chih, Okada, Motohiro, Nakatsu, Fubito, Ohno, Hiroshi, Kojima, Toshio. 2007. Mutation screening of AP3M2 in Japanese epilepsy patients. In Brain & development, 29, 462-7. doi:. https://pubmed.ncbi.nlm.nih.gov/17293072/
3. Bubier, Jason A, Jay, Jeremy J, Baker, Christopher L, Crabbe, John C, Chesler, Elissa J. 2014. Identification of a QTL in Mus musculus for alcohol preference, withdrawal, and Ap3m2 expression using integrative functional genomics and precision genetics. In Genetics, 197, 1377-93. doi:10.1534/genetics.114.166165. https://pubmed.ncbi.nlm.nih.gov/24923803/
4. Jin, Qianqian, Feng, Jiahao, Yan, Yang, Kuang, Yong. 2024. Prognostic and immunological role of adaptor related protein complex 3 subunit mu2 in colon cancer. In Scientific reports, 14, 483. doi:10.1038/s41598-023-50452-2. https://pubmed.ncbi.nlm.nih.gov/38177168/
5. Sullivan, Sarah E, Liao, Meichen, Smith, Robert V, De Jager, Philip L, Young-Pearse, Tracy L. . Candidate-based screening via gene modulation in human neurons and astrocytes implicates FERMT2 in Aβ and TAU proteostasis. In Human molecular genetics, 28, 718-735. doi:10.1093/hmg/ddy376. https://pubmed.ncbi.nlm.nih.gov/30371777/
6. Cui, Mingfu, Zhang, Haiyan, Han, Songyun, Shen, Zhaoming, Ding, Dayong. 2022. Screening of biomarkers associated with diagnosis and prognosis of colorectal cancer. In Genes & genetic systems, 97, 101-110. doi:10.1266/ggs.21-00072. https://pubmed.ncbi.nlm.nih.gov/36104170/